“Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway”. Nigerian Journal of Physiological Sciences, vol. 40, no. 2, Dec. 2025, pp. 251-62, https://doi.org/10.54548/.